CRISPR Therapeutics AG reported revenue of $10.18M and net income of -$93.84M for the quarter ended Jun 2026. This income statement covers 44 quarters of results from Sep 2015 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Sep2015 | Dec2015 | Mar2016 | Jun2016 | Sep2016 | Dec2016 | Mar2017 | Jun2017 | Sep2017 | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 76.46M | 76.99M | 77.39M | 77.79M | 78.25M | 78.51M | 78.86M | 79.37M | 79.43M | 80.04M | 84.84M | 85.05M | 85.34M | 85.74M | 86.36M | 88.38M | 93.87M | 95.89M | 96.39M | 96.66M | ||||||||||||||||||||||||
| Revenue & cost | ||||||||||||||||||||||||||||||||||||||||||||
| Revenue | 0.82M | 12.90M | 0.94M | 0.16M | 0.09M | 0.01M | 100.00M | 70.00M | 201.21M | 0.50M | 0.52M | 0.60M | 35.69M | 0.86M | 0.89M | 0.89M | 0.86M | 1.46M | 10.18M | |||||||||||||||||||||||||
| Operating items | ||||||||||||||||||||||||||||||||||||||||||||
| Research & DevelopmentR&D | 83.50M | 103.09M | 118.25M | 123.22M | 116.62M | 103.56M | 99.94M | 101.56M | 90.70M | 95.14M | 76.17M | 80.17M | 82.16M | 71.74M | 72.48M | 69.89M | 58.90M | 13.00M | 68.57M | 67.15M | ||||||||||||||||||||||||
| Selling, General & AdministrativeSG&A | 23.71M | 23.68M | 28.02M | 26.27M | 27.00M | 21.17M | 22.36M | 19.03M | 18.29M | 16.48M | 17.95M | 19.48M | 17.42M | 18.12M | 19.30M | 18.92M | 16.93M | 18.40M | 17.18M | 17.55M | ||||||||||||||||||||||||
| Other Operating ExpensesOther Opex | 22.46M | 31.82M | 30.65M | 33.92M | 38.86M | 6.82M | 42.19M | 44.64M | 23.42M | 20.00M | 46.97M | 52.13M | 11.15M | 10.42M | 57.51M | 141.41M | 57.12M | 124.23M | 45.95M | 42.74M | ||||||||||||||||||||||||
| Operating ExpensesOpex | 129.67M | 158.60M | 176.91M | 183.42M | 182.48M | 131.55M | 164.49M | 165.22M | 132.41M | 131.62M | 141.09M | 151.78M | 110.73M | 100.28M | 149.29M | 230.22M | 132.95M | 155.63M | 131.71M | 127.45M | ||||||||||||||||||||||||
| Operating IncomeOp. Inc | -128.85M | -145.70M | -175.97M | -183.26M | -182.39M | -131.54M | -64.49M | -95.22M | -132.41M | 69.58M | -140.59M | -151.26M | -110.13M | -64.59M | -148.42M | -229.32M | -132.06M | -154.76M | -130.25M | -117.27M | ||||||||||||||||||||||||
| EBIT | -128.85M | -145.70M | -175.97M | -183.26M | -182.39M | -131.54M | -64.49M | -95.22M | -132.41M | 69.58M | -140.59M | -151.26M | -110.13M | -64.59M | -148.42M | -229.32M | -132.06M | -154.76M | -130.25M | -117.27M | ||||||||||||||||||||||||
| Non-operating items | ||||||||||||||||||||||||||||||||||||||||||||
| Interest & Investment IncomeInt & Inv Inc | -0.12M | -4.30M | -11.80M | -3.38M | -1.82M | 6.50M | 6.23M | 0.45M | 2.16M | 8.65M | -3.45M | -1.33M | 13.37M | -8.64M | 2.25M | -0.17M | 0.97M | -0.17M | -6.73M | -2.69M | ||||||||||||||||||||||||
| Other Non Operating IncomeOther Non Op Inc. | 1.10M | 2.20M | 0.36M | 3.54M | 7.26M | 11.49M | 12.74M | 18.41M | 20.67M | 20.00M | 24.72M | 26.14M | 25.06M | 27.98M | 13.54M | 22.07M | 26.24M | 24.77M | 8.16M | 27.07M | ||||||||||||||||||||||||
| Non Operating IncomeNon Op. Inc. | 1.10M | 2.20M | 0.36M | 3.54M | 7.26M | 11.49M | 12.74M | 18.41M | 20.67M | 20.00M | 24.72M | 26.14M | 25.06M | 27.98M | 13.54M | 22.07M | 26.24M | 24.77M | 8.16M | 27.07M | ||||||||||||||||||||||||
| Net income details | ||||||||||||||||||||||||||||||||||||||||||||
| EBT | -127.75M | -143.50M | -175.61M | -179.72M | -175.12M | -121.37M | -51.74M | -76.82M | -111.74M | 59.22M | -115.87M | -125.12M | -85.07M | -77.84M | -134.89M | -207.26M | -105.82M | -162.53M | -122.09M | -90.19M | ||||||||||||||||||||||||
| Tax ProvisionsTaxes | -0.60M | -2.25M | 3.61M | 6.12M | -0.60M | -8.52M | 1.32M | 0.92M | 0.41M | 0.61M | 0.72M | 1.30M | 0.90M | 1.17M | 1.11M | 1.30M | 0.62M | 0.61M | 0.84M | 1.00M | ||||||||||||||||||||||||
| Profit After TaxPAT | -127.29M | -141.25M | -179.22M | -185.83M | -176.47M | -103.96M | -53.06M | -77.74M | -112.15M | 89.35M | -116.59M | -126.41M | -85.94M | -37.38M | -136.00M | -208.64M | -106.44M | -130.61M | -122.93M | -93.84M | ||||||||||||||||||||||||
| Equity Income | ||||||||||||||||||||||||||||||||||||||||||||
| Income from Non-Controlling InterestsInc. Minority | ||||||||||||||||||||||||||||||||||||||||||||
| Income from Continuing OperationsIncome (Continuing) | -127.15M | -141.25M | -179.22M | -185.83M | -174.52M | -112.86M | -53.06M | -77.74M | -112.15M | 58.61M | -116.59M | -126.42M | -85.97M | -79.01M | -136.00M | -208.56M | -106.44M | -163.14M | -122.93M | -91.19M | ||||||||||||||||||||||||
| Consolidated Net IncomeConsol Net Inc. | -127.15M | -141.25M | -179.22M | -185.83M | -174.52M | -112.86M | -53.06M | -77.74M | -112.15M | 58.61M | -116.59M | -126.42M | -85.97M | -79.01M | -136.00M | -208.56M | -106.44M | -163.14M | -122.93M | -91.19M | ||||||||||||||||||||||||
| Income towards Parent CompanyParent Net Inc | -127.15M | -141.25M | -179.22M | -185.83M | -174.52M | -112.86M | -53.06M | -77.74M | -112.15M | 58.61M | -116.59M | -126.42M | -85.97M | -79.01M | -136.00M | -208.56M | -106.44M | -163.14M | -122.93M | -91.19M | ||||||||||||||||||||||||
| Net Income towards Common StockholdersNet Income | -127.15M | -141.25M | -179.22M | -185.83M | -174.52M | -112.86M | -53.06M | -77.74M | -112.15M | 58.61M | -116.59M | -126.42M | -85.97M | -79.01M | -136.00M | -208.56M | -106.44M | -163.14M | -122.93M | -91.19M | ||||||||||||||||||||||||
| Additional items | ||||||||||||||||||||||||||||||||||||||||||||
| EPS (Basic) | -1.67 | -1.86 | -2.32 | -2.40 | -2.24 | -1.45 | -0.67 | -0.98 | -1.41 | 0.74 | -1.43 | -1.49 | -1.01 | -0.94 | -1.58 | -2.40 | -1.17 | -1.81 | -1.28 | -0.94 | ||||||||||||||||||||||||
| EPS (Diluted) | -1.67 | -1.76 | -2.32 | -2.40 | -2.24 | -1.45 | -0.67 | -0.98 | -1.41 | 0.74 | -1.43 | -1.49 | -1.01 | -0.94 | -1.58 | -2.40 | -1.17 | -1.81 | -1.28 | -0.94 | ||||||||||||||||||||||||
| Shares Outstanding | 76.29M | 75.95M | 77.10M | 77.51M | 78.02M | 77.75M | 78.68M | 79.09M | 79.41M | 79.22M | 81.79M | 84.92M | 85.23M | 84.36M | 85.94M | 87.07M | 91.31M | 89.93M | 96.05M | 96.51M | ||||||||||||||||||||||||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 76.29M | 80.39M | 77.10M | 77.51M | 78.02M | 77.75M | 78.68M | 79.09M | 79.41M | 79.22M | 81.79M | 84.92M | 85.23M | 84.36M | 85.94M | 87.07M | 91.31M | 89.93M | 96.05M | 96.51M | ||||||||||||||||||||||||
| EBITDA | -128.85M | -145.70M | -175.97M | -183.26M | -182.39M | -131.54M | -64.49M | -95.22M | -132.41M | 69.58M | -140.59M | -151.26M | -110.13M | -64.59M | -148.42M | -229.32M | -132.06M | -154.76M | -130.25M | -117.27M | ||||||||||||||||||||||||
| Tax Rate | 0.47 | 1.57 | -2.05 | -3.40 | 0.34 | 7.02 | -2.55 | -1.20 | -0.37 | 1.03 | -0.62 | -1.04 | -1.06 | -1.50 | -0.82 | -0.63 | -0.58 | -0.38 | -0.69 | -1.11 |